FPH.NZ - Fisher & Paykel Healthcare Corporation Limited
NEXT EARNINGS:
May 27, 2026
EPS Est: $0.40
|
Rev Est: $1.2B
Price:
--
--
Market Cap:
23.37B
Volume:
324,345
Avg Volume:
529,303
52 Week Range:
31.8-40.46
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.93
Last Dividend:
$0.43
Exchange:
NZE
Country:
NZ
Employees:
6,978
IPO Date:
2000-01-01
EPS (TTM):
0.59
P/E Ratio:
56.27
Revenue (TTM):
1.87B
Total Assets:
2.36B
Total Debt:
141.85M
Cash & Equiv:
244.74M
Rev Growth (5Y):
8.6%
EPS Growth (5Y):
3.4%
FCF Growth (5Y):
23.9%
ROCE:
24.9%
Debt/Equity:
0.08
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-25 | $0.36 | $0.35 | +5.3% | $1.1B | $1.1B | +1.4% |
| 2025-05-27 | $0.36 | $0.34 | +6.7% | $1.2B | $1.0B | +14.5% |
| 2024-11-28 | $0.28 | $0.29 | -2.7% | $1.0B | $1.0B | +3.7% |
| 2024-05-29 | $0.26 | $0.25 | +3.6% | $1.0B | $906.2M | +12.9% |
| 2023-11-29 | $0.20 | $0.17 | +12.8% | $876.1M | $795.2M | +10.2% |
| 2023-05-26 | $0.28 | $0.26 | +8.1% | $958.8M | $1.7B | -44.0% |
| 2022-11-29 | $0.19 | $0.16 | +17.6% | $790.4M | $674.8M | +17.1% |
| 2022-03-31 | $0.29 | $0.26 | +12.3% | $824.5M | $789.1M | +4.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.87B | 1.61B | 1.48B | 1.52B | 1.79B | 1.24B | 1.03B | 908.35M | 797.79M | 736.42M | 636.00M | 531.52M |
| Net Income | 349.03M | 121.57M | 233.18M | 348.36M | 482.79M | 279.85M | 200.58M | 179.13M | 155.20M | 129.04M | 111.76M | 90.72M |
| EPS | 0.59 | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.39 | 0.35 | 0.33 | 0.29 | 0.20 | 0.19 |
| Total Assets | 2.36B | 2.28B | 2.20B | 2.11B | 2.08B | 1.44B | 1.21B | 1.03B | 878.19M | 850.97M | 677.42M | 678.97M |
| Total Debt | 141.85M | 189.10M | 145.80M | 104.30M | 118.40M | 136.20M | 86.30M | 82.40M | 61.04M | 70.07M | 66.24M | 117.80M |
| Cash & Equivalents | 244.74M | 82.00M | 121.00M | 89.90M | 97.30M | 67.10M | 48.20M | 31.90M | 61.25M | 20.80M | 13.78M | 11.24M |
| Operating Cash Flow | 507.63M | 429.60M | 238.20M | 324.30M | 625.30M | 321.40M | 263.86M | 247.80M | 192.56M | 144.54M | 145.66M | 105.18M |
| Free Cash Flow | 439.52M | 90.60M | 26.90M | 154.50M | 440.60M | 150.70M | 125.00M | 164.60M | 123.96M | 71.57M | 91.47M | 70.84M |
| FCF per Share | 0.75 | 0.16 | 0.05 | 0.27 | 0.77 | 0.26 | 0.22 | 0.29 | 0.22 | 0.13 | 0.16 | 0.13 |
| Book Value | 1.75B | 1.76B | 1.75B | 1.68B | 1.52B | 973.80M | 913.20M | 761.40M | 661.62M | 601.13M | 476.54M | 437.47M |
| Cash & ST Investments | 244.74M | 82.00M | 121.00M | 289.90M | 377.60M | 144.80M | 140.70M | 132.30M | 61.25M | 20.80M | 13.78M | 11.24M |
| ROC Equity | 0.20 | 0.07 | 0.13 | 0.21 | 0.32 | 0.29 | 0.22 | 0.24 | 0.23 | 0.21 | 0.23 | 0.21 |